FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098380475> ?p ?o ?g. }

• W2098380475 endingPage "8" @default.
• W2098380475 startingPage "8" @default.
• W2098380475 abstract "Over the past several years a new era for patients requiring anticoagulation has arrived. The approval of new target specific oral anticoagulants offers practitioners several advantages over traditionally used vitamin K antagonist agents including predictable pharmacokinetics, rapid onset of action, comparable efficacy and safety, all without the need for routine monitoring. Despite these benefits, hemorrhagic complicates are inevitable with any anticoagulation treatment. One of the major disadvantages of the new oral anticoagulants is lack of specific antidotes or reversal agents for patients with serious bleeding or need for urgent surgery. As use of the new target specific oral anticoagulants continues to increase, practitioners will need to understand both the pharmacodynamics and pharmacokinetic properties of the agents, as well as, the available literature with use of non-specific therapies to reverse anticoagulation. Four factor prothrombin complex concentrates have been available for several years in Europe, and recently became available in the United States with approval of Kcentra. These products have shown efficacy in reversing anticoagulation from vitamin K antagonists, however their usefulness with the new target specific oral anticoagulants is poorly understood. This article will review the properties of dabigatran, rivaroxaban and apixaban, as well as the limited literature available on the effectiveness of prothrombin complex concentrates in reversal of their anticoagulant effects. Additional studies are needed to more accurately define the role of prothrombin complex concentrates in patients with life threatening bleeding or who require emergent surgery, as current data is both limited and conflicting." @default.
• W2098380475 created "2016-06-24" @default.
• W2098380475 creator A5033695572 @default.
• W2098380475 creator A5091384023 @default.
• W2098380475 date "2014-01-01" @default.
• W2098380475 modified "2023-10-16" @default.
• W2098380475 title "The role of prothrombin complex concentrates in reversal of target specific anticoagulants" @default.
• W2098380475 cites W1485772655 @default.
• W2098380475 cites W1575823155 @default.
• W2098380475 cites W1940756716 @default.
• W2098380475 cites W1966222151 @default.
• W2098380475 cites W1979888396 @default.
• W2098380475 cites W1980009210 @default.
• W2098380475 cites W1980595649 @default.
• W2098380475 cites W1982985719 @default.
• W2098380475 cites W1990272483 @default.
• W2098380475 cites W2011507589 @default.
• W2098380475 cites W2021472508 @default.
• W2098380475 cites W2031581415 @default.
• W2098380475 cites W2048075335 @default.
• W2098380475 cites W2050683323 @default.
• W2098380475 cites W2097854437 @default.
• W2098380475 cites W2098197296 @default.
• W2098380475 cites W2108064339 @default.
• W2098380475 cites W2117677020 @default.
• W2098380475 cites W2118615533 @default.
• W2098380475 cites W2119622751 @default.
• W2098380475 cites W2124149640 @default.
• W2098380475 cites W2131248096 @default.
• W2098380475 cites W2132090154 @default.
• W2098380475 cites W2136489990 @default.
• W2098380475 cites W2140681770 @default.
• W2098380475 cites W2162508946 @default.
• W2098380475 cites W2168664438 @default.
• W2098380475 cites W2203036336 @default.
• W2098380475 cites W2334285353 @default.
• W2098380475 cites W2481569543 @default.
• W2098380475 doi "https://doi.org/10.1186/1477-9560-12-8" @default.
• W2098380475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4014136" @default.
• W2098380475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24742134" @default.
• W2098380475 hasPublicationYear "2014" @default.
• W2098380475 type Work @default.
• W2098380475 sameAs 2098380475 @default.
• W2098380475 citedByCount "46" @default.
• W2098380475 countsByYear W20983804752014 @default.
• W2098380475 countsByYear W20983804752015 @default.
• W2098380475 countsByYear W20983804752016 @default.
• W2098380475 countsByYear W20983804752017 @default.
• W2098380475 countsByYear W20983804752018 @default.
• W2098380475 countsByYear W20983804752019 @default.
• W2098380475 countsByYear W20983804752020 @default.
• W2098380475 countsByYear W20983804752021 @default.
• W2098380475 countsByYear W20983804752023 @default.
• W2098380475 crossrefType "journal-article" @default.
• W2098380475 hasAuthorship W2098380475A5033695572 @default.
• W2098380475 hasAuthorship W2098380475A5091384023 @default.
• W2098380475 hasBestOaLocation W20983804751 @default.
• W2098380475 hasConcept C126322002 @default.
• W2098380475 hasConcept C141071460 @default.
• W2098380475 hasConcept C177713679 @default.
• W2098380475 hasConcept C2776301958 @default.
• W2098380475 hasConcept C2776413415 @default.
• W2098380475 hasConcept C2776704044 @default.
• W2098380475 hasConcept C2777091921 @default.
• W2098380475 hasConcept C2778205648 @default.
• W2098380475 hasConcept C2778382381 @default.
• W2098380475 hasConcept C2778661090 @default.
• W2098380475 hasConcept C2778810321 @default.
• W2098380475 hasConcept C2779161974 @default.
• W2098380475 hasConcept C2780290652 @default.
• W2098380475 hasConcept C2780638905 @default.
• W2098380475 hasConcept C2909974469 @default.
• W2098380475 hasConcept C2993590494 @default.
• W2098380475 hasConcept C71924100 @default.
• W2098380475 hasConceptScore W2098380475C126322002 @default.
• W2098380475 hasConceptScore W2098380475C141071460 @default.
• W2098380475 hasConceptScore W2098380475C177713679 @default.
• W2098380475 hasConceptScore W2098380475C2776301958 @default.
• W2098380475 hasConceptScore W2098380475C2776413415 @default.
• W2098380475 hasConceptScore W2098380475C2776704044 @default.
• W2098380475 hasConceptScore W2098380475C2777091921 @default.
• W2098380475 hasConceptScore W2098380475C2778205648 @default.
• W2098380475 hasConceptScore W2098380475C2778382381 @default.
• W2098380475 hasConceptScore W2098380475C2778661090 @default.
• W2098380475 hasConceptScore W2098380475C2778810321 @default.
• W2098380475 hasConceptScore W2098380475C2779161974 @default.
• W2098380475 hasConceptScore W2098380475C2780290652 @default.
• W2098380475 hasConceptScore W2098380475C2780638905 @default.
• W2098380475 hasConceptScore W2098380475C2909974469 @default.
• W2098380475 hasConceptScore W2098380475C2993590494 @default.
• W2098380475 hasConceptScore W2098380475C71924100 @default.
• W2098380475 hasIssue "1" @default.
• W2098380475 hasLocation W20983804751 @default.
• W2098380475 hasLocation W20983804752 @default.
• W2098380475 hasLocation W20983804753 @default.
• W2098380475 hasLocation W20983804754 @default.
• W2098380475 hasOpenAccess W2098380475 @default.
• W2098380475 hasPrimaryLocation W20983804751 @default.

• next